TIS tissue therapies limited

disappointed but still committed

  1. 219 Posts.
    lightbulb Created with Sketch. 3
    I unloaded some stocks last week to raise funds for the rights issue (WES being one of them and, of course, before their little surge at the end of the week).

    I was disappointed, when the trading halt was finally announced, to be greeted with the news of another CR. The gap between expectations and the reality has been gone over ad nauseum on another thread, so I won't go over all of that again.

    Nothing has changed regarding the speculative nature of the venture, nor of the high risk, nor (more importantly) the possibility of spectacularly large returns. This includes the chances of finalising a partnership deal - which are just as good (better even) as before.

    I will be putting another $20+ grand into this rights issue to take-up my entitlement and to get a little more to make up a nice round number.

    I very much doubt I'll be alone as the potential upside of TIS, if things actually go to plan (which is different to going "to schedule")is a company with a billion dollar market cap come 2015.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.